By: Grace Huff
First-ever Napier ALS Fellow begins July 1 at the Norman Fixel Institute for Neurological Diseases
Driven by personal experience and a desire to create a lasting impact, Florida Gators head football coach Billy Napier has made a philanthropic gift to help establish an ALS research fellowship at the Norman Fixel Institute for Neurological Diseases at UF Health. This gift honors the memory of Napier’s father, Bill, who passed away from ALS several years ago.
The newly created ALS Fellowship will support advanced training and research in amyotrophic lateral sclerosis, or ALS, also known as Lou Gehrig’s disease, a progressive and currently incurable neurodegenerative disease.
“My family and I are thankful for the work that is being done at the Fixel Institute. We are excited to partner with them to help in the research area to work towards solutions, improvement of processes relative to ALS and other neurological diseases,” said Napier.
The one-year fellowship will enable a fellow to focus on clinical research aimed at improving care and understanding of ALS, a mission deeply aligned with the goals of the Fixel Institute and Coach Napier’s inspiration.
“I’m especially passionate about the associations between neurodegenerative conditions and certain toxic exposures, such as pesticides, and occupational hazards, such as head trauma, said A. Enrique Martinez Nunez, M.D., the inaugural recipient of the fellowship.
His research during the fellowship will center on environmental and occupational factors that may influence ALS risk, an area of growing importance in understanding potential causes and prevention strategies.
“Coach Napier’s gift is a powerful example of how personal stories drive momentum in research and care,” said Michael Okun, M.D., director of the Norman Fixel Institute for Neurological Diseases at UF Health. “It reminds us that behind every research question is a patient, a family and a story that deserves to be heard and honored.”
The Fixel Institute hopes to advance ALS research and provide better treatment options for patients and their families affected by ALS.
“There is great leadership at the Fixel Institute. Dr. Okun and his team have been outstanding, and we are excited to see the impact of the work over the next year through the fellowship,” Napier said.